Cephalon, Barr Reach Agreement On Drug
Cephalon will give Barr Pharmaceuticals a license to sell a generic version of the pain drug Fentora in 2018 as part of a patent lawsuit settlement, according to a regulatory filing. Cephalon (CEPH) said it will give Barr a nonexclusive, royalty-free right to sell a generic version of Fentora in October of 2018. Cephalon claimed Barr infringed Fentora patents that don't expire until 2019. Under the settlement, Barr, a unit of Teva Pharmaceutical
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here